Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

0.4055 (USD) • At close April 17, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Omzet 00002.8460000000000000000
Kosten van de omzet 000.1350.1370.1350.4550.49100.4690.4510.440.4480.3290.1360.1220.09800000
Brutowinst 00-0.135-0.1372.711-0.455-0.4910-0.469-0.451-0.44-0.448-0.329-0.136-0.122-0.09800000
Brutowinstmarge 00000.9530000000000000000
Onderzoek- en ontwikkelingskosten 4.4894.6374.5844.9174.4933.8184.7845.2047.3459.196.3937.4555.9566.4435.8983.3652.5563.5762.8582.1952.425
Algemene en administratieve kosten 2.8343.1863.2033.8133.6493.9195.3935.8045.7034.7514.3195.0323.4573.8733.8864.6042.5211.7881.3111.9080.982
Verkoop- en marketingkosten 000-0.137-0.1350000000000000000
Verkoop-, algemene en administratieve kosten 2.8343.1863.2033.6763.5143.9195.3935.8045.7034.7514.3195.0323.4573.8733.8864.6042.5211.7881.3111.9080.982
Overige kosten 0.95100-0.002-0.0670.6130.06801.5650.020000.631-0.028-0.0030.7380000
Bedrijfskosten 8.2747.8237.7878.5938.0077.73710.17711.00813.04813.94110.71212.4879.41310.3169.7847.9695.0775.3644.1694.1033.407
Bedrijfsresultaat -8.274-7.823-7.787-8.73-8.142-7.737-10.177-11.008-13.048-13.941-10.712-12.487-9.413-10.316-9.784-7.969-5.077-5.364-4.907-4.103-3.407
Bedrijfsresultaat ratio 0000-2.8610000000000000000
Totaal overige inkomsten en kosten netto 0.5040.570.6450.7380.7280.6130.7910.8310.8160.5250.1770.0820.0470.6310.013-0.003-0.054-0.003-0.003-0.589-3.298
Inkomen voor belasting -7.77-7.253-7.142-7.992-7.414-7.124-9.386-10.177-12.232-13.416-10.535-12.405-9.366-9.685-9.771-7.972-5.131-5.367-4.91-4.692-6.705
Inkomen voor belasting ratio 0000-2.6050000000000000000
Belastingkosten 0000.0941.457-0.3320.10600.209-0.525-0.177-0.082-0.047-0.631-0.0130.0030.0540.0030.0030.5893.298
Nettowinst -7.77-7.253-7.142-7.992-7.414-7.124-9.386-10.177-12.441-12.891-10.358-12.323-9.366-9.685-9.771-7.972-5.131-5.367-4.91-4.692-6.705
Nettowinstmarge 0000-2.6050000000000000000
WPA (Winst Per Aandeel) -0.31-0.29-0.28-0.32-0.3-0.28-0.31-0.33-0.4-0.42-0.34-0.4-0.31-0.32-0.32-0.42-0.27-0.44-0.4-0.38-0.54
Verwaterde WPA -0.31-0.29-0.28-0.32-0.3-0.28-0.31-0.33-0.4-0.42-0.34-0.4-0.31-0.32-0.32-0.42-0.27-0.44-0.4-0.38-0.54
EBITDA -7.422-6.9-6.983-7.827-7.248-6.636-8.857-9.777-12.697-12.955-9.923-11.714-8.731-9.335-9.502-7.871-5.007-5.3-4.855-3.04-5.286
EBITDA ratio 0000-2.5470000000000000000